Efficacy of topical corticosteroids in nickel-induced contact allergy

Summary  In this study we used the nickel contact allergy patch (CAP) test to investigate the effect of topical corticosteroids on allergic contact dermatitis (ACD). On day 1, three CAP tests were applied for 48 h on the forearms of 20 female volunteers with a known nickel ACD. CAP of the right fore...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental dermatology 2002-01, Vol.27 (1), p.47-50
Hauptverfasser: Hachem, J. P., De Paepe, K., Vanpée, E., Bogaerts, M., Kaufman, L., Rogiers, V., Roseeuw, D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 50
container_issue 1
container_start_page 47
container_title Clinical and experimental dermatology
container_volume 27
creator Hachem, J. P.
De Paepe, K.
Vanpée, E.
Bogaerts, M.
Kaufman, L.
Rogiers, V.
Roseeuw, D.
description Summary  In this study we used the nickel contact allergy patch (CAP) test to investigate the effect of topical corticosteroids on allergic contact dermatitis (ACD). On day 1, three CAP tests were applied for 48 h on the forearms of 20 female volunteers with a known nickel ACD. CAP of the right forearm contained 5% nickel, and of the left forearm physiological saline. Clinical scoring, transepidermal water loss and skin hydration were measured on day 1 before CAP application, on day 4 (0, 2 and 6 h) after ACD and from days 5 to 8 (0 h). A topical corticosteroid and its vehicle were applied twice daily starting from day 4 on two ACD sites. Transepidermal water loss values were significantly decreased on the topical‐corticosteroid‐treated sites in the early phase of ACD (day 4, 6 h after the first application) while clinical efficacy showed significant improvement on days 7 and 8. The vehicle was found to improve skin hydration only on day 8. In conclusion the topical corticosteroid improved the skin barrier function in the early inflammatory phase of ACD (day 4, 6 h). The lack of improvement in transepidermal water loss in the later phase of ACD might be accounted for by the secondary effects of the corticosteroid on proliferation and differentiation of keratinocytes.
doi_str_mv 10.1046/j.0307-6938.2001.00963.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_201304020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>113026322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4763-c790c8df441669dd039434118233758cfef1e97d5699398340ee735fbdf840273</originalsourceid><addsrcrecordid>eNpFkUlPwzAQhS0EgrL8BRQhcUwYZxw7lrhAWwoSy4XlaAUvyCUkxUlF--9xaYGTR_L3ZvTeIyShkFFg_GyaAYJIucQyywFoBiA5ZostMqDIizTPEbbJ4A_aI_tdN40gUlHskj1KZZFzAQMyHjvndaWXSeuSvp3FuU50G3qv2663ofWmS3yTNF6_2zr1jZlrayLR9JXuk6qubXhbHpIdV9WdPdq8B-Tpavw4vE5vHyY3w4vbVDPBMdVCgi6NY4xyLo0BlAwZpWWOKIpSO-uolcIUXEqUJTKwVmDhXo0rGeQCD8jJeu8stJ9z2_Vq2s5DE0-qPJqDCEGEjjfQ_PXDGjUL_qMKS_VrOgKnG6Dqol0Xqkb77p9DUYIULHLna-7L13b5_w9qVYKaqlW-apWvWpWgfkpQCzUcj-IQ5ela7mOQiz95Fd4VF9GvermfqMvr0eTumb8oid96U4b9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201304020</pqid></control><display><type>article</type><title>Efficacy of topical corticosteroids in nickel-induced contact allergy</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Hachem, J. P. ; De Paepe, K. ; Vanpée, E. ; Bogaerts, M. ; Kaufman, L. ; Rogiers, V. ; Roseeuw, D.</creator><creatorcontrib>Hachem, J. P. ; De Paepe, K. ; Vanpée, E. ; Bogaerts, M. ; Kaufman, L. ; Rogiers, V. ; Roseeuw, D.</creatorcontrib><description>Summary  In this study we used the nickel contact allergy patch (CAP) test to investigate the effect of topical corticosteroids on allergic contact dermatitis (ACD). On day 1, three CAP tests were applied for 48 h on the forearms of 20 female volunteers with a known nickel ACD. CAP of the right forearm contained 5% nickel, and of the left forearm physiological saline. Clinical scoring, transepidermal water loss and skin hydration were measured on day 1 before CAP application, on day 4 (0, 2 and 6 h) after ACD and from days 5 to 8 (0 h). A topical corticosteroid and its vehicle were applied twice daily starting from day 4 on two ACD sites. Transepidermal water loss values were significantly decreased on the topical‐corticosteroid‐treated sites in the early phase of ACD (day 4, 6 h after the first application) while clinical efficacy showed significant improvement on days 7 and 8. The vehicle was found to improve skin hydration only on day 8. In conclusion the topical corticosteroid improved the skin barrier function in the early inflammatory phase of ACD (day 4, 6 h). The lack of improvement in transepidermal water loss in the later phase of ACD might be accounted for by the secondary effects of the corticosteroid on proliferation and differentiation of keratinocytes.</description><identifier>ISSN: 0307-6938</identifier><identifier>EISSN: 1365-2230</identifier><identifier>DOI: 10.1046/j.0307-6938.2001.00963.x</identifier><identifier>PMID: 11952670</identifier><identifier>CODEN: CEDEDE</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science, Ltd</publisher><subject>Administration, Cutaneous ; Adult ; Allergic diseases ; Androstadienes - therapeutic use ; Anti-Inflammatory Agents - therapeutic use ; Biological and medical sciences ; Dermatitis, Allergic Contact - drug therapy ; Dermatitis, Allergic Contact - etiology ; Dermatitis, Allergic Contact - physiopathology ; Dermatologic Agents - therapeutic use ; Double-Blind Method ; Female ; Fluticasone ; Glucocorticoids ; Humans ; Immunopathology ; Medical sciences ; Nickel - adverse effects ; Patch Tests ; Pharmacology. Drug treatments ; Skin allergic diseases. Stinging insect allergies ; Skin, nail, hair, dermoskeleton ; Treatment Outcome ; Water Loss, Insensible - drug effects</subject><ispartof>Clinical and experimental dermatology, 2002-01, Vol.27 (1), p.47-50</ispartof><rights>2003 INIST-CNRS</rights><rights>Copyright Blackwell Science Ltd. Jan 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4763-c790c8df441669dd039434118233758cfef1e97d5699398340ee735fbdf840273</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13780974$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11952670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hachem, J. P.</creatorcontrib><creatorcontrib>De Paepe, K.</creatorcontrib><creatorcontrib>Vanpée, E.</creatorcontrib><creatorcontrib>Bogaerts, M.</creatorcontrib><creatorcontrib>Kaufman, L.</creatorcontrib><creatorcontrib>Rogiers, V.</creatorcontrib><creatorcontrib>Roseeuw, D.</creatorcontrib><title>Efficacy of topical corticosteroids in nickel-induced contact allergy</title><title>Clinical and experimental dermatology</title><addtitle>Clin Exp Dermatol</addtitle><description>Summary  In this study we used the nickel contact allergy patch (CAP) test to investigate the effect of topical corticosteroids on allergic contact dermatitis (ACD). On day 1, three CAP tests were applied for 48 h on the forearms of 20 female volunteers with a known nickel ACD. CAP of the right forearm contained 5% nickel, and of the left forearm physiological saline. Clinical scoring, transepidermal water loss and skin hydration were measured on day 1 before CAP application, on day 4 (0, 2 and 6 h) after ACD and from days 5 to 8 (0 h). A topical corticosteroid and its vehicle were applied twice daily starting from day 4 on two ACD sites. Transepidermal water loss values were significantly decreased on the topical‐corticosteroid‐treated sites in the early phase of ACD (day 4, 6 h after the first application) while clinical efficacy showed significant improvement on days 7 and 8. The vehicle was found to improve skin hydration only on day 8. In conclusion the topical corticosteroid improved the skin barrier function in the early inflammatory phase of ACD (day 4, 6 h). The lack of improvement in transepidermal water loss in the later phase of ACD might be accounted for by the secondary effects of the corticosteroid on proliferation and differentiation of keratinocytes.</description><subject>Administration, Cutaneous</subject><subject>Adult</subject><subject>Allergic diseases</subject><subject>Androstadienes - therapeutic use</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Dermatitis, Allergic Contact - drug therapy</subject><subject>Dermatitis, Allergic Contact - etiology</subject><subject>Dermatitis, Allergic Contact - physiopathology</subject><subject>Dermatologic Agents - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Fluticasone</subject><subject>Glucocorticoids</subject><subject>Humans</subject><subject>Immunopathology</subject><subject>Medical sciences</subject><subject>Nickel - adverse effects</subject><subject>Patch Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Skin allergic diseases. Stinging insect allergies</subject><subject>Skin, nail, hair, dermoskeleton</subject><subject>Treatment Outcome</subject><subject>Water Loss, Insensible - drug effects</subject><issn>0307-6938</issn><issn>1365-2230</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkUlPwzAQhS0EgrL8BRQhcUwYZxw7lrhAWwoSy4XlaAUvyCUkxUlF--9xaYGTR_L3ZvTeIyShkFFg_GyaAYJIucQyywFoBiA5ZostMqDIizTPEbbJ4A_aI_tdN40gUlHskj1KZZFzAQMyHjvndaWXSeuSvp3FuU50G3qv2663ofWmS3yTNF6_2zr1jZlrayLR9JXuk6qubXhbHpIdV9WdPdq8B-Tpavw4vE5vHyY3w4vbVDPBMdVCgi6NY4xyLo0BlAwZpWWOKIpSO-uolcIUXEqUJTKwVmDhXo0rGeQCD8jJeu8stJ9z2_Vq2s5DE0-qPJqDCEGEjjfQ_PXDGjUL_qMKS_VrOgKnG6Dqol0Xqkb77p9DUYIULHLna-7L13b5_w9qVYKaqlW-apWvWpWgfkpQCzUcj-IQ5ela7mOQiz95Fd4VF9GvermfqMvr0eTumb8oid96U4b9</recordid><startdate>200201</startdate><enddate>200201</enddate><creator>Hachem, J. P.</creator><creator>De Paepe, K.</creator><creator>Vanpée, E.</creator><creator>Bogaerts, M.</creator><creator>Kaufman, L.</creator><creator>Rogiers, V.</creator><creator>Roseeuw, D.</creator><general>Blackwell Science, Ltd</general><general>Blackwell</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>200201</creationdate><title>Efficacy of topical corticosteroids in nickel-induced contact allergy</title><author>Hachem, J. P. ; De Paepe, K. ; Vanpée, E. ; Bogaerts, M. ; Kaufman, L. ; Rogiers, V. ; Roseeuw, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4763-c790c8df441669dd039434118233758cfef1e97d5699398340ee735fbdf840273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Administration, Cutaneous</topic><topic>Adult</topic><topic>Allergic diseases</topic><topic>Androstadienes - therapeutic use</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Dermatitis, Allergic Contact - drug therapy</topic><topic>Dermatitis, Allergic Contact - etiology</topic><topic>Dermatitis, Allergic Contact - physiopathology</topic><topic>Dermatologic Agents - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Fluticasone</topic><topic>Glucocorticoids</topic><topic>Humans</topic><topic>Immunopathology</topic><topic>Medical sciences</topic><topic>Nickel - adverse effects</topic><topic>Patch Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Skin allergic diseases. Stinging insect allergies</topic><topic>Skin, nail, hair, dermoskeleton</topic><topic>Treatment Outcome</topic><topic>Water Loss, Insensible - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hachem, J. P.</creatorcontrib><creatorcontrib>De Paepe, K.</creatorcontrib><creatorcontrib>Vanpée, E.</creatorcontrib><creatorcontrib>Bogaerts, M.</creatorcontrib><creatorcontrib>Kaufman, L.</creatorcontrib><creatorcontrib>Rogiers, V.</creatorcontrib><creatorcontrib>Roseeuw, D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Clinical and experimental dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hachem, J. P.</au><au>De Paepe, K.</au><au>Vanpée, E.</au><au>Bogaerts, M.</au><au>Kaufman, L.</au><au>Rogiers, V.</au><au>Roseeuw, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of topical corticosteroids in nickel-induced contact allergy</atitle><jtitle>Clinical and experimental dermatology</jtitle><addtitle>Clin Exp Dermatol</addtitle><date>2002-01</date><risdate>2002</risdate><volume>27</volume><issue>1</issue><spage>47</spage><epage>50</epage><pages>47-50</pages><issn>0307-6938</issn><eissn>1365-2230</eissn><coden>CEDEDE</coden><abstract>Summary  In this study we used the nickel contact allergy patch (CAP) test to investigate the effect of topical corticosteroids on allergic contact dermatitis (ACD). On day 1, three CAP tests were applied for 48 h on the forearms of 20 female volunteers with a known nickel ACD. CAP of the right forearm contained 5% nickel, and of the left forearm physiological saline. Clinical scoring, transepidermal water loss and skin hydration were measured on day 1 before CAP application, on day 4 (0, 2 and 6 h) after ACD and from days 5 to 8 (0 h). A topical corticosteroid and its vehicle were applied twice daily starting from day 4 on two ACD sites. Transepidermal water loss values were significantly decreased on the topical‐corticosteroid‐treated sites in the early phase of ACD (day 4, 6 h after the first application) while clinical efficacy showed significant improvement on days 7 and 8. The vehicle was found to improve skin hydration only on day 8. In conclusion the topical corticosteroid improved the skin barrier function in the early inflammatory phase of ACD (day 4, 6 h). The lack of improvement in transepidermal water loss in the later phase of ACD might be accounted for by the secondary effects of the corticosteroid on proliferation and differentiation of keratinocytes.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science, Ltd</pub><pmid>11952670</pmid><doi>10.1046/j.0307-6938.2001.00963.x</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0307-6938
ispartof Clinical and experimental dermatology, 2002-01, Vol.27 (1), p.47-50
issn 0307-6938
1365-2230
language eng
recordid cdi_proquest_journals_201304020
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Alma/SFX Local Collection
subjects Administration, Cutaneous
Adult
Allergic diseases
Androstadienes - therapeutic use
Anti-Inflammatory Agents - therapeutic use
Biological and medical sciences
Dermatitis, Allergic Contact - drug therapy
Dermatitis, Allergic Contact - etiology
Dermatitis, Allergic Contact - physiopathology
Dermatologic Agents - therapeutic use
Double-Blind Method
Female
Fluticasone
Glucocorticoids
Humans
Immunopathology
Medical sciences
Nickel - adverse effects
Patch Tests
Pharmacology. Drug treatments
Skin allergic diseases. Stinging insect allergies
Skin, nail, hair, dermoskeleton
Treatment Outcome
Water Loss, Insensible - drug effects
title Efficacy of topical corticosteroids in nickel-induced contact allergy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T13%3A26%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20topical%20corticosteroids%20in%20nickel-induced%20contact%20allergy&rft.jtitle=Clinical%20and%20experimental%20dermatology&rft.au=Hachem,%20J.%20P.&rft.date=2002-01&rft.volume=27&rft.issue=1&rft.spage=47&rft.epage=50&rft.pages=47-50&rft.issn=0307-6938&rft.eissn=1365-2230&rft.coden=CEDEDE&rft_id=info:doi/10.1046/j.0307-6938.2001.00963.x&rft_dat=%3Cproquest_pubme%3E113026322%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201304020&rft_id=info:pmid/11952670&rfr_iscdi=true